Randomized controlled trial evidence that estrogen replacement therapy reduces the progression of subclinical atherosclerosis in healthy postmenopausal women without preexisting cardiovascular disease - Response
Publication
, Journal Article
Herrington, DM; Howard, TD; Brosnihan, B; Hawkins, GA; Reboussin, DM; Xu, JF; Zheng, SQL; Meyers, DA; Bleeker, ER; McDonnell, DP; Li, XL
Published in: CIRCULATION
July 8, 2003
Duke Scholars
Published In
CIRCULATION
ISSN
0009-7322
Publication Date
July 8, 2003
Volume
108
Issue
1
Start / End Page
E5 / E5
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Herrington, D. M., Howard, T. D., Brosnihan, B., Hawkins, G. A., Reboussin, D. M., Xu, J. F., … Li, X. L. (2003). Randomized controlled trial evidence that estrogen replacement therapy reduces the progression of subclinical atherosclerosis in healthy postmenopausal women without preexisting cardiovascular disease - Response. CIRCULATION, 108(1), E5–E5.
Herrington, D. M., T. D. Howard, B. Brosnihan, G. A. Hawkins, D. M. Reboussin, J. F. Xu, S. Q. L. Zheng, et al. “Randomized controlled trial evidence that estrogen replacement therapy reduces the progression of subclinical atherosclerosis in healthy postmenopausal women without preexisting cardiovascular disease - Response.” CIRCULATION 108, no. 1 (July 8, 2003): E5–E5.
Herrington DM, Howard TD, Brosnihan B, Hawkins GA, Reboussin DM, Xu JF, et al. Randomized controlled trial evidence that estrogen replacement therapy reduces the progression of subclinical atherosclerosis in healthy postmenopausal women without preexisting cardiovascular disease - Response. CIRCULATION. 2003 Jul 8;108(1):E5–E5.
Herrington, D. M., et al. “Randomized controlled trial evidence that estrogen replacement therapy reduces the progression of subclinical atherosclerosis in healthy postmenopausal women without preexisting cardiovascular disease - Response.” CIRCULATION, vol. 108, no. 1, LIPPINCOTT WILLIAMS & WILKINS, July 2003, pp. E5–E5.
Herrington DM, Howard TD, Brosnihan B, Hawkins GA, Reboussin DM, Xu JF, Zheng SQL, Meyers DA, Bleeker ER, McDonnell DP, Li XL. Randomized controlled trial evidence that estrogen replacement therapy reduces the progression of subclinical atherosclerosis in healthy postmenopausal women without preexisting cardiovascular disease - Response. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2003 Jul 8;108(1):E5–E5.
Published In
CIRCULATION
ISSN
0009-7322
Publication Date
July 8, 2003
Volume
108
Issue
1
Start / End Page
E5 / E5
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology